Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

An old pharma tradition: if possible do not spell out unfavorable data, only imply.

BTW: Soligenix did exactly same thing with dusquetide - reported numbers for cisplatin Q3W group and left calculating the results for really awful weekly cisplatin group to rare enterprising reader. And then they made things interesting by accidentally (????) publishing wrong head counts for cisplatin Q3W group. Thanks to ClinicalTrials.gov consistency checkers the correct head counts enabling calculation of the results for cisplatin Q1W group can be found there.

As you can see, IPIX bunch are just amateurs...they forgot to fudge headcounts.